Kelly Clark, MD, MBA, DFASAM, DFAPA

Kelly Clark, MD, MBA, DFASAM, DFAPA

Board certified in both addiction medicine and psychiatry, Kelly J. Clark, MD, MBA, DFAPA, DFASAM is a practicing physician, business leader and recognized expert on issues related to substance misuse involving opioids as well as other illicit and prescription substances.

Known for building consensus across diverse stakeholder groups, Dr. Clark works actively across the medical, scientific, criminal justice, and business communities to transform addiction care into evidence-based, cost-effective practice. Her approach to the U.S. drug crisis is summarized in her comments to the Presidential Opioid Commission: “We need to stop doing what we know doesn’t work and put our resources behind what we know does.” As Immediate Past President of the American Society of Addiction Medicine (ASAM), the national association that represents more than 6,500 addiction physician specialists and allied health professionals, she helped the organization lead bipartisan and multi-stakeholder coalitions to pass new legislation and policies.   Dr. Clark serves as a leader in the National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic, and  served as a contributing consultant to the recent “Opioids and the Workplace: An Employer Toolkit for Supporting Prevention, Treatment, and Recovery” with the Kentuckiana Health Collaborative.

Considered one of the nation’s leading experts on substance use disorder and addiction care, she is frequently invited to testify about the disease of addiction and needed systems of treatment before Congress and to federal organizations and other drug policy stakeholders, including the United States Presidential Opioid Commission, Bipartisan Heroin and Opioid Task Force, the Food and Drug Administration (FDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Justice (DOJ) Civil Rights and Criminal Divisions, the Office of Comptroller General, the National Association of Attorneys General, the National Association for the Advancement of Science, Pew Trusts, National Safety Council, National Business Group on Health, American Psychiatric Association Foundation’s Judges and Psychiatrists Initiative, and the Council of State Governments’ Justice and Mental Health Collaboration Program.

Scroll to Top